Novel uses for recombinant erythropoietin therapy in unlicensed indications.


Autoria(s): Macartney, C.A.; Adgey, A.A.; Jones, F.G.; Morris, T C M; McMullin, Mary
Data(s)

2004

Identificador

http://pure.qub.ac.uk/portal/en/publications/novel-uses-for-recombinant-erythropoietin-therapy-in-unlicensed-indications(c497255b-c5c0-47cf-91ca-f0ba5be87945).html

http://dx.doi.org/10.1038/sj.thj.6200350

http://www.scopus.com/inward/record.url?scp=1942441697&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Macartney , C A , Adgey , A A , Jones , F G , Morris , T C M & McMullin , M 2004 , ' Novel uses for recombinant erythropoietin therapy in unlicensed indications. ' The hematology journal : the official journal of the European Haematology Association / EHA , vol 5(2) , no. 2 , pp. 181-185 . DOI: 10.1038/sj.thj.6200350

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2720 #Hematology
Tipo

article